Biotechnology
- U.S. News
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and…
Read More » - U.S. News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew…
Read More » - U.S. News
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax…
Read More » - U.S. News
Walgreens says it will close 1,200 stores by 2027, as earnings top estimates
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov.…
Read More » - Europe
Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated…
Read More » - U.S. News
CVS is under pressure and considering a break up. Here’s why that could be risky
A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty Images…
Read More » - U.S. News
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s…
Read More » - U.S. News
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie…
Read More » - U.S. News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on Aug. 10, 2022. Christopher Goodney…
Read More » - U.S. News
FTC sues drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen…
Read More »
